Order Article Reprints

Takigawa N, Ochi N, Nakagawa N, Nagasaki Y, Taoka M, Ichiyama N, Mimura A, Nakanishi H, Kohara H, Yamane H. Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors? Cancers. 2020; 12(7):1995. https://doi.org/10.3390/cancers12071995

Takigawa, Nagio, Nobuaki Ochi, Nozomu Nakagawa, Yasunari Nagasaki, Masataka Taoka, Naruhiko Ichiyama, Ayaka Mimura, Hidekazu Nakanishi, Hiroyuki Kohara, and Hiromichi Yamane. 2020. "Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?" Cancers 12, no. 7: 1995. https://doi.org/10.3390/cancers12071995

Takigawa, N., Ochi, N., Nakagawa, N., Nagasaki, Y., Taoka, M., Ichiyama, N., Mimura, A., Nakanishi, H., Kohara, H., & Yamane, H. (2020). Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors? Cancers, 12(7), 1995. https://doi.org/10.3390/cancers12071995